SLEEP BREATHING DISORDERS IN PATIENTS WITH ATRIAL FIBRILLATION
Abstract
The data are given on the relationship between the sleep breathing disorders (predominantly, obstructive sleep apnea) with atrial fibrillation and their effect on the outcomes in subjects with the arrhythmia.
About the Authors
S. G. Akobyan
ФГБУ «Северо-Западный федеральный медицинский исследовательский центр имени В.А.Алмазова» МЗ РФ
Russian Federation
Russian Federation
L. S. Korostovtseva
ФГБУ «Северо-Западный федеральный медицинский исследовательский центр имени В.А.Алмазова» МЗ РФ
Russian Federation
Russian Federation
S. Yu. Varenitsyna
ФГБУ «Северо-Западный федеральный медицинский исследовательский центр имени В.А.Алмазова» МЗ РФ
Russian Federation
Russian Federation
A. P. Semenov
ФГБУ «Северо-Западный федеральный медицинский исследовательский центр имени В.А.Алмазова» МЗ РФ
Russian Federation
Russian Federation
M. V. Bochkarev
ФГБУ «Северо-Западный федеральный медицинский исследовательский центр имени В.А.Алмазова» МЗ РФ
Russian Federation
Russian Federation
Yu. V. Sviryaev
ФГБУ «Северо-Западный федеральный медицинский исследовательский центр имени В.А.Алмазова» МЗ РФ; ФГБУН «Институт эволюционной физиологии и биохимии имени И.М. Сеченова» РАН
Russian Federation
Russian Federation
References
1. Van Wagoner D.R., Piccini J.P., Albert C.M., Anderson M.E. Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013.
2. Shao X.H., Yang Y.M., Zhu J., Zhang H. et al. Comparison of the clinical features and outcomes in two age-groups of elderly patients with atrial fibrillation. Clin Interv Aging. 2014; 9: 1335-1342. doi: 10.2147/CIA.S67123.
3. Wдndell P.E., Carlsson A.C., Sundquist J., Johansson S.E. Pharmacotherapy and mortality in atrial fibrillation-a cohort of men and women 75 years or older in Sweden. Age Ageing. 2015; 44(2): 232-238. doi: 10.1093/ageing/afu153.
4. Reiffel J.A. Atrial fibrillation and stroke: epidemiology. Am J Med. 2014; 127(4): e15-e16.
5. Ревишвили А.Ш., Сулимов В.А. Фибрилляция и трепетание предсердий. Кардиология. Национальное руководство. 2015.
6. Peppard P.E., Young T., Barnet J.H., Palta M. Increased prevalence of sleep-disordered breathing in adults. Am. J. Epidemiol. 2013 May 1; 177 (9): 1006-14.
7. Левин Я.И., Полуэктов М.Г. Расстроиства сна и их лечение // Consilium medicum. 2008. No 2. С. 137-142.
8. Michelena H., Powell B.D., Brady P.A., Friedman P.A. Gender in atrial fibrillation: Ten years later. Gend Med. 2010 Jun; 7(3): 206-17. doi: 10.1016/j.genm.2010.06.001.
9. Lavie P. Who was the first to use the term Pickwickian in connection with sleepy patients? History of sleep apnoea syndrome. Sleep Med Rev. 2008; 12(1): 5-17.
10. Bhattacharyya N., Blake S.P., Fried M.P. Assessment of the airway in obstructive sleep apnea syndrome with 3-dimensional airway computed tomography. Otolaryngology: head and neck surgery 2000; 123: 444-449.
11. Eckert D.J., Malhotra A. Pathophysiology of Adult Obstructive Sleep Apnea. Proceedings of the American thoracic society 2008; 5: 144-153.
12. Rivlin J., Hoffstein V., Kalbfleisch J, McNicholas W. Upper airway morphology in patients with idiopathic obstructive sleep apnea. Am. Rev. Respir. Dis. 1984 Mar; 129 (3): 355-60.
13. Gami A.S., Pressman G., Caples S.M., Kanagala R. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004 Jul 27; 110(4): 364-7.
14. Szymanski F.M., Platek A.E., Karpinski G. et al. Obstructive sleep apnea in patients with atrial fibrillation: prevalence, determinants and clinical characteristics of patients in Polish population. Kardiol Pol. 2014; 72: 716-24.
15. Mehra R., Benjamin E.J., Shahar E., Gottlieb D.J. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am. J. Respir. Crit. Care Med. 2006 Apr 15; 173 (8): 910-6.
16. Tanigawa T., Yamagishi K., Sakurai S., Muraki I. Arterial oxygen desaturation during sleep and atrial fibrillation. Heart. 2006 Dec; 92 (12): 1854-5.
17. Foster G.E., Poulin M.J., Hanly P.J. Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea. Exp Physiol. 2007; 92(1): 51-65.
18. Gami A.S., Hodge D.O., Herges R.M., et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. Journal of the American College of Cardiology 2007; 49: 565- 571.
19. Вейн А.М. Синдром апноэ во сне и другие расстройства дыхания, связанные со сном: клиника, диагностика, лечение. М.: 2002; 310 с
20. Mooe T., Gullsby S., Rabben T., Eriksson P. Sleep-disordered breathing: a novel predictor of atrial fibrillation after coronary artery bypass surgery. Coron Artery Dis. 1996 Jun; 7(6): 475-8.
21. Hendrikx T., Sundqvist M., Sandstrцm H., Sahlin C. Atrial fibrillation among patients under investigation for suspected obstructive sleep apnea. 2017 Feb DOI: 10.1371/journal.pone.0171575
22. Poli M., Philip P., Taillard J., Debruxelles S. Atrial fibrillation is a major cause of stroke in apneic patients: a prospective study. Sleep Med. 2017 Feb; 30: 251-254. doi: 10.1016/j.sleep.2015.07.031. Epub 2016 Mar 4.
23. Szymanski F.M., Lip G.Y., Filipiak K.J., Platek A. Stroke Risk Factors Beyond the CHA2DS2-VASc Score: Can We Improve Our Identification of “High Stroke Risk” Patients With Atrial Fibrillation? 2015 Dec 1; 116(11): 1781-8. doi: 10.1016/j.amjcard.2015.08.049. Epub 2015 Sep 11.
24. Ling Z., Yuemei H., Sunny S. P. Obstructive Sleep Ap-noea and Atrial Fibrillation
25. Rossi V.A., Kohler M. Effects of obstructive sleep apnoea on heart rhythm // Eur. Respir. J.2013. Vol.41.P.1439-1451
26. Narkiewicz K., Van de Borne P.J., Cooley R.L., Dyken M.E. Sympathetic activity in obese subjects with and without obstructive sleep apnea._Circulation. 1998 Aug 25; 98(8): 772-6.
27. Narkiewicz K., Van de Borne P.J., Montano N., Dyken M.E. Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea._Circulation. 1998 Mar 17; 97(10): 943-5.
28. Osanai S., Akiba Y., Fujiuchi S., Nakano H. Depression of peripheral chemosensitivity by a dopaminergic mechanism in patients with obstructive sleep apnoea syndrome. Eur Respir J. 1999; 13(2): 418-423.
29. Mahamed S., Hanly P.J., Gabor J., Beecroft J. Overnight changes of chemoreflex control in obstructive sleep apnoea patients. Respir Physiol Neurobiol. 2005; 146(2- 3): 279-90.
30. Foster G.E., Poulin M.J., Hanly P.J. Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea. Exp Physiol. 2007; 92(1): 51-65.
31. Shamsuzzaman A.S., Gersh B.J., Somers V.K. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA. 2003 Oct 8; 290(14): 1906-14.
32. Somers V.K., Dyken M.E., Skinner J.L. Autonomic and hemodynamic responses and interactions during the Mueller maneuver in humans // J. Auton. Nerv. Syst. 1993. Vol. 44. P. 2530-259.
33. Linz D., Mahfoud F., Linz B., et al. Effect of obstructive respiratory events on blood pressure and renal perfusion in a pig model for sleep apnea, Am. J. Hypertens. 27 (2014) 1293-1300.
34. Linz D., Hohl M., Nickel A., et al. Effect of renal denervation on neurohumoral acti- vation triggering atrial fibrillation in obstructive sleep apnea, Hypertension 62 (2013) 767-774.
35. Mшller D.S., Lind P., Strunge B., Pedersen E.B. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea, Am. J. Hypertens. 16 (2003) 274e80.
36. Ramos P., Rubies C., Torres M., et al. Atrial fibrosis in a chronic murine model of obstructive sleep apnea: mechanisms and prevention by mesenchymal stem cells, Respir. Res. 15 (2014) 54.
37. Ehrlich J.R., Hohnloser S.H., Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence, Eur. Heart J. 27 (2006) 512-518.
38. Li D., Shinagawa K., Pang L., et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing induced congestive heart failure, Circulation 104 (2001) 2608-2614.
39. Reil J.C., Hohl M., Selejan S., et al. Aldosterone promotes atrial fibrillation, Eur. Heart J. 33 (2012) 20982108.
40. Tsai C.T., Chiang F.T., Tseng C.D., et al. Increased expression of mineralocorticoid re-ceptor in human atrial fibrillation and a cellular model of atrial fibrillation, J. Am. Coll. Cardiol. 55 (2010) 758-770.
41. Madrid A.H., Bueno M.G., Rebollo J.M., Marнn I. et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation. 2002 Jul 16; 106(3): 331-6.
42. Schmieder R.E., Kjeldsen S.E., Julius S., McInnes G.T. VALUE Trial Group. Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial. J Hypertens. 2008 Mar; 26(3): 403-11.
43. Бузунов Р.В., Ерошина В.А., Легейда И.В. Храп и синдром обструктивного апноэ сна: учебное пособие для врачеи. М., 2007.
44. Гончаров А.П., Волов Н.А., Шавдюк О.Ю., Таратухин Е.О. Синдром ночного апноэ как фактор риска сердечно-сосудистои патологии (обзор литературы) // Новые медицинские технологии. 2010. No 5.
45. Сидоренко Б.А., Ерошина Е.В. Синдром обструктивного апноэ сна и нарушения ритма сердца // Кардиология. 2006. No 10. С. 44-50.
46. Верткин А.Л., Максимова М.Ю., Любшина О.В. Нарушения сна у больных артериальной гипертензией и избыточной массой тела // Кардиоваскулярная терапия и профилактика. 2010. No 3. С. 10-19.
47. Parati G., Lombardi C., Hedner J., Bonsignore MR. Recommendations for the management of patients with obstructive sleep apnoea and hypertension. Eur Respir J. 2013 Mar; 41(3): 523-38. doi: 10.1183/09031936.00226711. Epub 2013 Feb 8.
48. Parati G., Lombardi C., Hedner J., Bonsignore MR. European Respiratory Society; EU COST ACTION B26 members. Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea. J Hypertens. 2012 Apr; 30(4): 633-46. doi: 10.1097/HJH.0b013e328350e53b.
49. Bradley T.D., Hall M.J., Ando S.I., Floras J.S. Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure, Chest 119 (2001) 1827 -1835.
50. Bradley T.D., Floras, J.S. Sleep apnea and heart failure, part I: obstructive sleep apnea, Circulation 107 (2003) 1671-1678.
51. Orban M., Bruce C.J., Pressman G.S., et al., Dynamic changes of left ventricular performance and left atrial volume induced by the mueller maneuver in healthy young adults and implications for obstructive sleep apnea, atrial fibrillation, and heart failure, Am. J. Cardiol. 102 (2008) 1557-1561.
52. Koshino Y., Villarraga H.R., Orban M., et al. Changes in left and right ventricular mechanics during the Mueller maneuver in healthy adults: a possible mechanism for abnormal cardiac function in patients with obstructive sleep apnea, Circulation 3 (2010) 282-289
53. Shivalkar B., Van de Heyning C., Kerremans M., Rinkevich D. Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. Am Coll Cardiol. 2006 Apr 4; 47(7): 1433-9.
54. Fung J.W., Li T.S., Choy D.K., et al. Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction, Chest 121 (2002) 422-429. [55]
55. Pini, G. Tourkohoriti, Jordanoglou J. Left ventricular function in patients with obstructive sleep apnoea before and after treatment with nasal continuous positive airway pressure, Respiration 67 (2000) 1632-1666.
56. Otto M.E., Belohlavek M., Romero-Corral A., Gami A.S. et all. Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea.
57. Colish J., Walker J.R., Elmayergi N., Almutairi S. Obstructive sleep apnea: effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI.
58. Кушаковский М.С. Аритмии сердца. - Спб: Гиппократ, 1992. - 544 с.
59. Shamsuzzaman A.S., Winnicki M., Lanfranchi P. et al., Elevated C-reactive protein in patients with obstructive sleep apnea, Circulation 105 (2002) 2462e4.
60. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Kales A. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity, J. Clin. Endocrinol. Metab. 82 (1997) 1313-1316.
61. Zouaoui B.K., Van Meerhaeghe A., Doumit S., et al., Sleep apnoea- hypopnoea index is an independent predictor of high-sensitivity c-reactive protein elevation, Respiration 73 (2006) 243-246.
62. Ohga E., Tomita T., Wada H., Yamamoto H. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1, J. Appl. Physiol. 94 (2003) 179e84.
63. Wu N., Xu B., Xiang Y., et al. Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: a meta-analysis, Int. J. Cardiol. 169 (2013) 62-72.
64. Cai B.Z., Gong D.M., Liu Y., Pan Z.W. Homocysteine inhibits potassium channels in human atrial myocytes. Clin Exp Pharmacol Physiol. 2007 Sep; 34(9): 851-5.
65. Marcucci R., Betti I., Cecchi E., Poli D. Hyperhomo-cysteinemia and vitamin B6 deficiency: new risk markers for nonvalvular atrial fibrillation? Am Heart J. 2004 Sep; 148(3): 456-61.
66. Can M., Aзikgцz S., Mungan G., Bayraktaroрlu T. Serum cardiovascular risk factors in obstructive sleep apnea. Chest. 2006 Feb; 129(2): 233-7.
67. Lavie L., Perelman A., Lavie P. Plasma homocysteine levels in obstructive sleep apnea: association with cardiovascular morbidity. Chest. 2001 Sep; 120(3): 900-8.
68. Rubinsztajn R., Kumor M., Byskiniewicz K., Chazan R. The influence of 3 weeks therapy with continuous positive airway pressure on serum leptin and homocysteine concentration in patients with obstructive sleep apnea syndrome. Pneumonol Alergol Pol. 2006; 74(1): 63-7.
69. Svatikova A., Wolk R., Magera M.J., Shamsuzzaman A.S. Plasma homocysteine in obstructive sleep apnoea. Eur Heart J. 2004 Aug; 25(15): 1325-9.
70. Eckert D.J., Jordan A.S., Merchia P., Malhotra A. Central sleep apnea: Pathophysiology and treatment. Chest. 2007 Feb; 131 (2): 595-607.
71. Sin D.D., Fitzgerald F., Parker J.D., Newton G. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am. J. Respir. Crit. Care Med. 1999 Oct; 160 (4): 1101-6.
72. Leung R.S., Huber M.A., Rogge T., Maimon N. Association between atrial fibrillation and central sleep apnea.
73. Grimm W., Sass J., Cassel W., Hildebrandt O. Severe central sleep apnea is associated with atrial fibrillation in patients with left ventricular systolic dysfunction. DOI: 10.1111/pace.12495
74. Friberg L., Hammar N., Rosenqvist M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation.
75. Watson T., Shantsila E., Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited.
76. Oliver, K.M. Hypoxia activates NF-kB-dependent gene expression through the canonical signaling pathway / K.M. Oliver, J.F. Garvey, C.T. Ng [et al.] // Antioxid Redox Signal. - 2009. - Vol. 11. - P. 2057-2064.
77. Hui D.S., Ko F.W., Fok J.P. (2004) The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest 125: 17681775. DOI 10.1378/chest.09-1778
78. Szymanski F.M., Filipiak K.J., Platek A.E., Hrynkiewicz-Szymanska A. Assessment of CHADS2 and CHA 2DS 2-VASc scores in obstructive sleep apnea patients with atrial fibrillation, Sleep Breath. 19 (2015) 531-537.
79. Yaranov D.M., Smyrlis A., Usatii N., et al., Effect of obstructive sleep apnea on frequency of stroke in patients with atrial fibrillation, Am. J. Cardiol. 115 (2015) 461 -465.
80. Platek A.E., Szymanski F.M., Filipiak K.J., Kotkowski M. Which components of the CHA2DS2-VASc score are the most important in ob- structive sleep apnea patients with atrial fibrillation? Blood Coagul. Fibrinolysis 27 (2016) 347-351.
81. Szymanski F.M., Lip G.Y., Filipiak K.J., Platek A.E. Stroke risk factors beyond the CHA2DS2-VASc score: can we improve our identification of “high stroke risk” patients with atrial fibrillation? Am. J. Cardiol. 116 (2015) 1781-1788.
82. Kanagala R., Murali N.S., Friedman P.A., Ammash N. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003 May 27; 107 (20): 2589-94.
83. Patricia T. Atrial Fibrillation And Sleep Apnea: Considerations For A Dual Epidemic
84. Holmqvist F., Guan N., Zhu Z., Kowey P.R., et all. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am. Heart J. 2015 May; 169 (5): 647-654.e2.
Review
For citations:
Akobyan S.G., Korostovtseva L.S., Varenitsyna S.Yu., Semenov A.P., Bochkarev M.V., Sviryaev Yu.V. SLEEP BREATHING DISORDERS IN PATIENTS WITH ATRIAL FIBRILLATION. Journal of Arrhythmology. 2017;(90):39-46. (In Russ.)
Views:
607
Email this article 